Stay updated with breaking news from Extra Crunch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
Several European-based insurtech startups entered unicorn territory this year, such as Bought By Many, which offers pet insurance; London-based Zego; and Alan, a French startup that raised a $220 million round. According to Brittain, EU startups in this sector are “still at the very early stages of innovation,” having only shown “a fraction of what’s possible” in a market that is “as large as banking.” Thanks very much for reading Extra Crunch; I hope you have a safe, relaxing weekend.
What do these 4 IPOs tell us about the state of the market? We’re digging into the final IPO prices set by fintech unicorn Marqeta and enterprise productivity unicorn Monday.com this morning. Briefly, it’s good news. A small programming note: The Exchange is off next week. I am taking some time to do nothing other than eat, read books and lose at lawn games. Regular service will resume the week after. The Exchange explores startups, markets and money. To catch up on this busy IPO week, Marqeta, Monday.com and two other IPOs are on the docket. The final pair are Zeta Global and 1stDibs,...
The imbalanced landscape of hormonal health Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. For this week’s deep dive, Alex, Natasha and Chris dug into the world of hormonal health, a sub-sector within the massive (and booming) world of digital health. The show was inspired by Natasha’s latest Extra Crunch piece: “Hormonal Health is a massive opportunity: Where are the unicorns?”. To round out the show, we asked one of the featured founders, Dr. Elizabeth Ruzzo, to hop on the mic and help us understand...
AI rounds are particularly hot or at least as hot as the larger SaaS market, which is itself enjoying historically rich multiples as more capital pours into the aggregate startup world.